+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glutamate Receptor"

CNS Therapeutics - Global Market Trajectory & Analytics - Product Thumbnail Image

CNS Therapeutics - Global Market Trajectory & Analytics

  • Report
  • February 2022
  • 978 Pages
From
Dystonia - Pipeline Insight, 2022 - Product Thumbnail Image

Dystonia - Pipeline Insight, 2022

  • Clinical Trials
  • June 2022
  • 60 Pages
From
Ionotropic Glutamate Receptor Antagonists - Pipeline Insight, 2022 - Product Thumbnail Image

Ionotropic Glutamate Receptor Antagonists - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 100 Pages
From
Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2022 - Product Thumbnail Image

Acetylcholine Receptor (AChR) Antagonists - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 80 Pages
From
Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2022 - Product Thumbnail Image

Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
Glutamate Receptor Antagonists - Pipeline Insight, 2022 - Product Thumbnail Image

Glutamate Receptor Antagonists - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
From
Status Epilepticus - Pipeline Insight, 2021 - Product Thumbnail Image

Status Epilepticus - Pipeline Insight, 2021

  • Drug Pipelines
  • September 2021
  • 60 Pages
From
West Syndrome - Pipeline Insight, 2021 - Product Thumbnail Image

West Syndrome - Pipeline Insight, 2021

  • Drug Pipelines
  • July 2021
  • 60 Pages
From
Amyotrophic Lateral Sclerosis Market Insight, Epidemiology and Market Forecast - 2030 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Market Insight, Epidemiology and Market Forecast - 2030

  • Report
  • March 2021
  • 200 Pages
From
Refractory Status Epilepticus - Pipeline Insight, 2021 - Product Thumbnail Image

Refractory Status Epilepticus - Pipeline Insight, 2021

  • Clinical Trials
  • February 2021
  • 60 Pages
From
Market Spotlight: Huntington's Disease - Product Thumbnail Image

Market Spotlight: Huntington's Disease

  • Report
  • January 2021
  • 32 Pages
2020 Autism spectrum disorders (ASD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs - Product Thumbnail Image

2020 Autism spectrum disorders (ASD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

  • Report
  • February 2020
  • 127 Pages
From
Glutamate Receptor Ionotropic NMDA 2B - Pipeline Review, H2 2019 - Product Thumbnail Image

Glutamate Receptor Ionotropic NMDA 2B - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 54 Pages
From
Parkinson's Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects - Product Thumbnail Image

Parkinson's Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects

  • Report
  • May 2019
  • 84 Pages
From
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2018 - Product Thumbnail Image

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2018

  • Drug Pipelines
  • July 2018
  • 41 Pages
From
Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) - Pipeline Review, H1 2018 - Product Thumbnail Image

Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) - Pipeline Review, H1 2018

  • Drug Pipelines
  • June 2018
  • 43 Pages
From
Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 36 Pages
From
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 32 Pages
From
Glutamate Receptor Ionotropic NMDA 2B Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Glutamate Receptor Ionotropic NMDA 2B Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

  • Report
  • May 2022
  • 95 Pages
From
Loading Indicator